Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.545
-0.125 (-2.68%)
Sep 10, 2026, 10:46 AM EDT - Market open
Foghorn Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -64.58 | -74.28 | -86.62 | -98.43 | -108.88 | -101.32 |
Depreciation & Amortization | 2.12 | 3.33 | 3.12 | 3.45 | 3.32 | 3.23 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | - | 0 | 0.01 | - |
Asset Writedown & Restructuring Costs | 5.91 | 5.91 | 2.4 | - | - | - |
Loss (Gain) From Sale of Investments | -1.67 | -1.93 | -4.61 | -2.65 | -1.3 | 0.18 |
Stock-Based Compensation | 9.91 | 10.4 | 11.89 | 16.19 | 14.34 | 8.38 |
Other Operating Activities | 0.71 | 2.57 | 5.68 | 5.21 | 4.58 | 5.84 |
Change in Accounts Receivable | - | - | - | - | 300 | -300 |
Change in Accounts Payable | -0.12 | 0.48 | -2.48 | 0.85 | 1.61 | 0.14 |
Change in Unearned Revenue | -36.74 | -30.91 | -22.6 | -34.16 | -14.23 | 336.48 |
Change in Other Net Operating Assets | 0.18 | -1.71 | -7.19 | -8.57 | -5.84 | -3.17 |
Operating Cash Flow | -84.24 | -86.1 | -100.41 | -118.11 | 193.61 | -50.25 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.05 | -0.05 | -0.91 | -1.22 | -1.21 | -3.31 |
Investment in Securities | 28.17 | 112.09 | -29 | 145.67 | -243.11 | 39.49 |
Investing Cash Flow | 28.12 | 112.04 | -29.9 | 144.45 | -244.32 | 36.17 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | - | -21.21 |
Net Debt Issued (Repaid) | - | - | - | - | - | -21.21 |
Issuance of Common Stock | 50.73 | 1.02 | 106.01 | 1.78 | 1.76 | 43.62 |
Other Financing Activities | -0.35 | - | -0.59 | - | - | - |
Financing Cash Flow | 50.38 | 1.02 | 105.43 | 1.78 | 1.76 | 22.42 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -5.74 | 26.96 | -24.88 | 28.12 | -48.95 | 8.34 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -84.29 | -86.15 | -101.31 | -119.33 | 192.4 | -53.56 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -229.43% | -278.72% | -448.24% | -349.38% | 1000.63% | -4060.88% |
Free Cash Flow Per Share | -1.27 | -1.37 | -1.84 | -2.84 | 4.63 | -1.44 |
Levered Free Cash Flow | -51.95 | -35.23 | -40.3 | -48.87 | 250.45 | -329.38 |
Unlevered Free Cash Flow | -51.95 | -35.23 | -40.3 | -48.87 | 250.45 | -328.18 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 1.72 |
Cash Income Tax Paid | 0 | 0.01 | 0.86 | 3.55 | - | - |
Change in Working Capital | -36.68 | -32.14 | -32.27 | -41.88 | 281.55 | 33.44 |